Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

VetFamily Højbjerg Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.4% 1.1% 1.1% 1.3% 2.0% 2.0% 19.7% 19.7%   Credit score (0-100)   80 85 84 79 67 67 6 6   Credit rating   A A A A A A B B   Credit limit (kDKK)   24.3 100.4 154.9 67.4 0.6 0.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,888 3,885 4,238 4,899 6,177 7,643 0.0 0.0   EBITDA   1,133 1,103 1,206 1,886 2,766 3,625 0.0 0.0   EBIT   930 813 808 1,525 2,446 3,357 0.0 0.0   Pre-tax profit (PTP)   1,052.8 908.5 931.2 1,510.6 4,211.0 3,358.8 0.0 0.0   Net earnings   841.6 728.3 754.8 1,174.5 3,674.7 2,619.7 0.0 0.0   Pre-tax profit without non-rec. items   1,053 908 931 1,511 4,211 3,359 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   671 1,562 1,206 845 361 307 0.0 0.0   Shareholders equity total   1,402 1,530 1,785 2,359 2,513 2,933 188 188   Interest-bearing liabilities   0.0 800 800 0.0 28.8 23.1 0.0 0.0   Balance sheet total (assets)   2,669 3,515 4,506 3,961 4,046 5,039 188 188   Net Debt   -718 110 -883 -1,886 -2,707 -3,626 -188 -188     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,888 3,885 4,238 4,899 6,177 7,643 0.0 0.0   Gross profit growth   7.2% -0.1% 9.1% 15.6% 26.1% 23.7% -100.0% 0.0%   Employees   6 6 6 6 7 8 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 16.7% 14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,669 3,515 4,506 3,961 4,046 5,039 188 188   Balance sheet change%   22.2% 31.7% 28.2% -12.1% 2.1% 24.5% -96.3% 0.0%   Added value   1,133.1 1,103.1 1,206.3 1,886.2 2,806.9 3,624.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -221 600 -753 -723 -804 -322 -307 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   23.9% 20.9% 19.1% 31.1% 39.6% 43.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   43.6% 30.3% 24.4% 36.5% 105.8% 73.9% 0.0% 0.0%   ROI %   89.5% 49.6% 38.0% 60.4% 172.9% 122.2% 0.0% 0.0%   ROE %   71.3% 49.7% 45.5% 56.7% 150.8% 96.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   52.5% 43.5% 39.6% 59.6% 62.1% 58.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -63.4% 10.0% -73.2% -100.0% -97.9% -100.0% 0.0% 0.0%   Gearing %   0.0% 52.3% 44.8% 0.0% 1.1% 0.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 7.4% 6.0% 8.7% 182.4% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 1.3 1.6 1.6 2.0 1.9 0.0 0.0   Current Ratio   1.5 1.6 1.8 1.9 2.3 2.2 0.0 0.0   Cash and cash equivalent   718.1 689.9 1,683.2 1,886.4 2,736.0 3,649.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   600.6 692.5 1,425.3 1,384.4 1,957.9 2,431.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   189 184 201 314 401 453 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   189 184 201 314 395 453 0 0   EBIT / employee   155 136 135 254 349 420 0 0   Net earnings / employee   140 121 126 196 525 327 0 0